158 related articles for article (PubMed ID: 31721714)
1. Herbal Medicine of the 21st Century: A Focus on the Chemistry, Pharmacokinetics and Toxicity of Five Widely Advocated Phytotherapies.
Suroowan S; Mahomoodally MF
Curr Top Med Chem; 2019; 19(29):2718-2738. PubMed ID: 31721714
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes.
He N; Edeki T
Am J Ther; 2004; 11(3):206-12. PubMed ID: 15133536
[TBL] [Abstract][Full Text] [Related]
3. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.
Vaghela M; Sahu N; Kharkar P; Pandita N
Chem Biol Interact; 2017 Dec; 278():141-151. PubMed ID: 29042257
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of metabolism-mediated herb-drug interactions.
Na DH; Ji HY; Park EJ; Kim MS; Liu KH; Lee HS
Arch Pharm Res; 2011 Nov; 34(11):1829-42. PubMed ID: 22139684
[TBL] [Abstract][Full Text] [Related]
5. An update on the ability of St. John's wort to affect the metabolism of other drugs.
Rahimi R; Abdollahi M
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):691-708. PubMed ID: 22606944
[TBL] [Abstract][Full Text] [Related]
6. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects.
Robertson SM; Davey RT; Voell J; Formentini E; Alfaro RM; Penzak SR
Curr Med Res Opin; 2008 Feb; 24(2):591-9. PubMed ID: 18205997
[TBL] [Abstract][Full Text] [Related]
7. Disposition pathways and pharmacokinetics of herbal medicines in humans.
He SM; Li CG; Liu JP; Chan E; Duan W; Zhou SF
Curr Med Chem; 2010; 17(33):4072-113. PubMed ID: 20939821
[TBL] [Abstract][Full Text] [Related]
8. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo.
Mohutsky MA; Anderson GD; Miller JW; Elmer GW
Am J Ther; 2006; 13(1):24-31. PubMed ID: 16428919
[TBL] [Abstract][Full Text] [Related]
10. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
[TBL] [Abstract][Full Text] [Related]
11. Herb-drug interactions and toxicity: Underscoring potential mechanisms and forecasting clinically relevant interactions induced by common phytoconstituents via data mining and computational approaches.
Suroowan S; Abdallah HH; Mahomoodally MF
Food Chem Toxicol; 2021 Oct; 156():112432. PubMed ID: 34293424
[TBL] [Abstract][Full Text] [Related]
12. Anti-Inflammatory Drugs and Herbs with Special Emphasis on Herbal Medicines for Countering Inflammatory Diseases and Disorders - A Review.
Yatoo MI; Gopalakrishnan A; Saxena A; Parray OR; Tufani NA; Chakraborty S; Tiwari R; Dhama K; Iqbal HMN
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):39-58. PubMed ID: 29336271
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of potential inductive effects of aprepitant on cytochrome P450 3A4 and 2C9 activity.
Shadle CR; Lee Y; Majumdar AK; Petty KJ; Gargano C; Bradstreet TE; Evans JK; Blum RA
J Clin Pharmacol; 2004 Mar; 44(3):215-23. PubMed ID: 14973304
[TBL] [Abstract][Full Text] [Related]
14. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.
Gorski JC; Huang SM; Pinto A; Hamman MA; Hilligoss JK; Zaheer NA; Desai M; Miller M; Hall SD
Clin Pharmacol Ther; 2004 Jan; 75(1):89-100. PubMed ID: 14749695
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.
Ufer M
Clin Pharmacokinet; 2005; 44(12):1227-46. PubMed ID: 16372822
[TBL] [Abstract][Full Text] [Related]
16. Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review.
Nazari S; Rameshrad M; Hosseinzadeh H
Phytother Res; 2017 Nov; 31(11):1635-1650. PubMed ID: 28833680
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp.
Li X; Hu J; Wang B; Sheng L; Liu Z; Yang S; Li Y
Toxicol Appl Pharmacol; 2014 Mar; 275(2):163-75. PubMed ID: 24380838
[TBL] [Abstract][Full Text] [Related]
18. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
[TBL] [Abstract][Full Text] [Related]
19. Clinical herbal interactions with conventional drugs: from molecules to maladies.
Chen XW; Serag ES; Sneed KB; Liang J; Chew H; Pan SY; Zhou SF
Curr Med Chem; 2011; 18(31):4836-50. PubMed ID: 21919844
[TBL] [Abstract][Full Text] [Related]
20. Fatal seizures due to potential herb-drug interactions with Ginkgo biloba.
Kupiec T; Raj V
J Anal Toxicol; 2005 Oct; 29(7):755-8. PubMed ID: 16419414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
